METHODS: Using an established rhabdomyosarcoma based model of EV-D68 infection we directly compared proliferative capacity of ATCC VR-1826 EV-D68 (fermon) virus to that of VR-1823 (epidemic) EV-D68. RT-PCR utilizing EV-D68 specific primers and probes was used to compare delta Ct values of the two EV-D68 strains at different time points following inoculation. Indirect immunofluorescence was employed to compare the time course of VP2 protein appearance on rhabdomyosarcoma cells following infection. Graphpad Prism software was utilized to perform student t-test on PCR data and assess statistical significance between groups with significance set at p<0.05
RESULTS: EV-D68 virus derived from the 2014 epidemic was able to proliferate with a 1.6 fold increase in genome copy number over 24 hours compared to an increase of 1.09 in the fermon strain by RT-PCR (p<0.001). VP2 protein of EV-D68 was first detected at 7 hours post-infection compared with 10 hours for the fermon strain.
CONCLUSIONS: The 2014 epidemic EV-D68 strain displays an increased proliferative capacity when compared to the 1962 fermon strain, probably attributed to the previously described point mutations.